The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Safety, toxicity and activity of multi-kinase inhibitor vandetanib in combination with everolimus in advanced solid tumors.
 
Tina Cascone
No Relationships to Disclose
 
Kenneth R. Hess
Travel, Accommodations, Expenses - Angiochem
 
Sarina Anne Piha-Paul
No Relationships to Disclose
 
David S. Hong
Research Funding - Amgen; AstraZeneca; Daiichi Sankyo; Eisai; Genentech; Lilly; Merck; Mirati Therapeutics; miRNA Therapeutics; Novartis; Pfizer
Travel, Accommodations, Expenses - Loxo; miRNA Therapeutics
 
Ishwaria Mohan Subbiah
No Relationships to Disclose
 
Tarak Bhatt
No Relationships to Disclose
 
Siqing Fu
No Relationships to Disclose
 
Aung Naing
Research Funding - Amplimmune; ARMO BioSciences; Atterocor; Baxter (I); EMD Serono; Healios; Incyte; Karyopharm Therapeutics; MedImmune; NCI; Novartis; Regeneron
Travel, Accommodations, Expenses - ARMO BioSciences
 
Filip Janku
Consulting or Advisory Role - Deciphera; Foundation Medicine; Novartis; Sequenom; Trovagene
Research Funding - Agios; Astellas Pharma; Biocartis; BioMed Valley Discoveries; Deciphera; Foundation Medicine; Novartis; Roche; Trovagene
Other Relationship - Bio-Rad
 
Daniel D. Karp
No Relationships to Disclose
 
Funda Meric-Bernstam
Honoraria - Genentech; Roche
Consulting or Advisory Role - Celgene; Genentech; Inflection Biosciences; Novartis; Roche
Research Funding - Aileron Therapeutics; AstraZeneca; Bayer; Calithera Biosciences; CytomX Therapeutics; Debiopharm Group; Genentech; Novartis; PUMA Biotechnology; Taiho Pharmaceutical; Verastem
 
John Heymach
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Exelixis; Genentech; GlaxoSmithKline; Lilly; Novartis
Research Funding - AstraZeneca; Bayer; GlaxoSmithKline
 
Vivek Subbiah
Research Funding - Abbvie (Inst); Amgen (Inst); Bayer (Inst); Berg Pharma (Inst); Bioxell Pharma (Inst); D3 Oncology Solutions (Inst); Fujifilm (Inst); Genentech (Inst); GlaxoSmithKline (Inst); Incyte (Inst); Multivir (Inst); NanoCarrier (Inst); Northwest Biotherapeutics (Inst); Novartis (Inst); Pfizer (Inst); PharmaMar (Inst)